GlassScriptPhysician profile
Catherine Heagy
NPI 1366980179
$739.61
in general payments reported to CMS, 2019-2025
9 companies · $50.42 in 2025
The $50.42 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.29 · 2022: $141 · 2023: $202 · 2024: $298 · 2025: $50.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.02 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $362.09 | 2023-2025 | Enhertu |
| Novocure INC. | $181.74 | 2021-2025 | Optune Lua (Novottf-200t), Optune |
| Astrazeneca Pharmaceuticals LP | $59.89 | 2023 | Imfinzi, Enhertu |
| Astellas Pharma US INC | $37.11 | 2021-2023 | Xtandi |
| Progenics Pharmaceuticals, INC. | $25.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.35 | 2023 | |
| Myovant Sciences INC. | $20.61 | 2022 | |
| Sumitomo Pharma America, INC. | $15.57 | 2023 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $15.04 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Heagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.